| Line Item | 2025-05-30 | Y/Y |
|---|---|---|
| Revenue | $59.0M | -10.9% |
| Cost of Revenue | $35.0M | +4.0% |
| Gross Profit | $23.9M | -26.5% |
| R&D Expense | $10.5M | +20.0% |
| SG&A Expense | $18.3M | +33.0% |
| Operating Income | -$5.7M | -156.3% |
| Pre-tax Income | -$4.3M | -134.4% |
| Income Tax | -$381K | +98.2% |
| Net Income | -$3.9M |
| Line Item | 2025-05-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.5M | -50.1% |
| Inventory | $42.0M | +12.1% |
| Current Assets | $88.8M | -9.3% |
| Total Assets | $148.5M | +16.1% |
| Current Liabilities | $15.6M | +48.8% |
| Total Liabilities | $25.6M | +57.1% |
| Stockholders' Equity | $122.9M | +10.1% |
| Line Item | 2025-05-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | -521.4% |
| Capital Expenditures | $5.0M | +566.5% |
| Investing Cash Flow | -$16.1M | -193.1% |
| Financing Cash Flow | $625K | +349.6% |
| Free Cash Flow | -$12.4M | -1330.6% |
| -111.8% |
| EPS (Basic) | -$0.13 | -111.3% |
| EPS (Diluted) | -$0.13 | -111.6% |